Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 8-K call announcement, 10-K stay in one workspace.
UPB
$2.79
+1.45%
UPB
· Upstream Bio, Inc.
$2.79
+0.04 (+1.45%)
At close · Oct 27
Return incl. dividend (before tax)
Going-concern doubt
— cleared May 13, 2026
The latest filing states the doubt was alleviated.
“The Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year from the issuance of these condensed consolidated financial statements. The Company expects its cash, cash equivalents and short-term investments will be sufficient to fund its operating expenses and capital expenditure requirements for at least the next twelve months from the date of issuance of these condensed consolidated financial statements.”View the 10-Q filed May 13, 2026
Market Cap
$153.63M
Shares
54.77M
Volume · Oct 27
1.18M
Avg daily vol (3M)
817.31K
All webcasts
Earnings call · FY2025 Q4
Upstream Bio, Inc. (UPB) Q4 2025 Earnings Call
Revenue · derived Q4
$668,000
+9% YoY
Net income · derived Q4
-$42.46M
Research coverage
4 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Feb 11, 2026 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 26, 2026 · complete as-filed document
SEC call announcement
8-K call announcement
Filed Feb 11, 2026 · complete as-filed document